Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:focusesOn |
Phase I clinical trials
Phase II clinical trials |
| gptkbp:founded |
2010
|
| gptkbp:headquartersLocation |
gptkb:Lincoln,_Nebraska,_United_States
|
| gptkbp:industry |
gptkb:contract_research_organization
clinical research |
| gptkbp:offersService |
biometrics
clinical pharmacology bioanalytical services early clinical research |
| gptkbp:officeLocation |
gptkb:Zelienople,_Pennsylvania,_United_States
gptkb:Phoenix,_Arizona,_United_States gptkb:Lincoln,_Nebraska,_United_States Belfast, Northern Ireland, United Kingdom |
| gptkbp:parentCompany |
gptkb:MDS_Pharma_Services_(predecessor)
|
| gptkbp:website |
https://www.celerion.com/
|
| gptkbp:bfsParent |
gptkb:AEA_Investors
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Celerion
|